About this trial
Cardiotocography (CTG) is a cornerstone of intrapartum fetal monitoring but requires a minimum of 30 minutes for a reliable trace, creating a significant bottleneck in high-volume, low-resource settings like Egypt As it is time-consuming and resource intensive. This leads to delays in care and increased workload for healthcare providers. A shortened, yet accurate, CTG protocol could drastically improve workflow and resource allocation without compromising fetal safety.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Singleton pregnancy.
Gestational age ≥ 37 weeks.
Vertex presentation.
Active first stage of labor (cervical dilation ≥ 4 cm).
Disqualifiers
• Multiple gestation.
Known major fetal anomaly.
Non-vertex presentation.
Indication for continuous CTG (e.g., meconium-stained liquor, antepartum hemorrhage).
Trial population
All women who come to Women's Health Assiut university hospital in labor and meet the inclusion criteria after informed consent.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
To compare the diagnostic accuracy (sensitivity, specificity, PPV, NPV) of a 10 minute CTG versus a standard 30-minute CTG in fetal monitoring and well being
Using fetal acidemia defined as (umbilical venous pH \< 7.25) as reference in detecting fetal will being and comparing results with 10-min \& 30-min CTG monitoring to evaluate diagnostic accuracy of both in detecting fetal acidemia.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: